Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presenter: a unique disease association in the highly active antiretroviral therapy (HAART) era

References

1. Palella FJ, Delaney KM, Moorman AC. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853–860 [CrossRef]
   [Google Scholar]
2. Floridia M, Fragola V, Galluzzo CM. et al. HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of <50 cells/μL): an analysis of 338 clinical events from a randomized clinical trial. HIV Med 2002; 3:75–84 [CrossRef]
   [Google Scholar]
3. Forrest DM, Seminari E, Hogg RS. et al. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin Infect Dis 1998; 27:1379–1385 [CrossRef]
   [Google Scholar]
4. Manfredi R, Chiodo F. Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study. Sex Transm Infect 2000; 76:145–146 [CrossRef]
   [Google Scholar]
5. Manfredi R, Calza L, Chiodo F. Lack of change in the distribution of AIDS-defining opportunistic diseases and the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2001; 20:410–413
   [Google Scholar]
6. Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol 2000; 38 Suppl 1:269–279 [CrossRef]
   [Google Scholar]
7. NCCLS Performance standards for antimicrobial susceptibility testing: eleventh informational supplement (January 2002. National Centers for Clinical and Laboratory Standards 2002; 22:1–124
   [Google Scholar]
8. Kyriazis AP, Kyriazis AA. Incidence and distribution of opportunistic lung infections in AIDS patients related to intravenous drug use: a study of bronchoalveolar lavage cytology by the Diff-Quik stain. Diagn Cytopathol 1993; 9:487–491 [CrossRef]
   [Google Scholar]
9. Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: analysis of data in annual reports of the pathological autopsy cases in Japan. J Clin Microbiol 1999; 37:1732–1738
   [Google Scholar]
10. Kaminski Z. Various opportunistic infections and neoplasms in patients dying of AIDS in the last 12 years – report based on pathomorphological investigations. Med Sci Monit 2001; 7:421–426
    [Google Scholar]
11. Shibuya K, Coulson WF, Wollman JS. et al. Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome. Int J Infect Dis 2001; 5:78–85 [CrossRef]
    [Google Scholar]
12. Reed JA, Slater LN, Hemann BA, Brigati DJ. Dual organism infection in biopsy specimens from immunocompromised patients: two cases demonstrated by immunocytochemistry. Clin Lab Anal 1993; 7:168–173 [CrossRef]
    [Google Scholar]
13. Mess T, Daar ES. Utility of fungal blood cultures for patients with AIDS. Clin Infect Dis 1997; 25:1350–1353 [CrossRef]
    [Google Scholar]
14. Garbino J, Kolarova L, Lew D, Hirschel B, Rohner P. Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospital. AIDS Patient Care STDs 2001; 15:407–410 [CrossRef]
    [Google Scholar]